Skip to search formSkip to main contentSkip to account menu

Opana

Known as: Endo brand of oxymorphine HCl 
National Institutes of Health

Related topics

Related topics

4 relations
1 ML Oxymorphone Hydrochloride 1 MG/ML Injection [Opana]12 HR Oxymorphone Hydrochloride 10 MG Extended Release Oral Tablet [Opana]

Broader (2)

OxymorphoneOxymorphone Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
Abstract Opana (oxymorphone) is a powerful semi-synthetic opioid agonist used for chronic pain management that is ingested orally… 
2017
2017
Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.
BACKGROUND Atypical Haemolytic Uremic Syndrome (aHUS) is a rare life threatening entity characterized by thrombocytopenia… 
Review
2017
Review
2017
Untangling the web of opioid addictions in the USA
Review
2016
Review
2016
Primary care providers' prescribing practices of opioid controlled substances.
OBJECTIVE Prescription opioid abuse poses a significant public health concern. House Bill 1 (HB1) was enacted in 2012 to address… 
2016
2016
THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH OPANA ER INTRAVENOUS ABUSE A Case Report.
Thrombotic microangiopathy is characterized by endothelial changes and microvascular stenosis. Several entities such as pregnancy… 
2014
2014
Changes in prescriptions of OxyContin and Opana after introduction of tamper resistant formulations among potentially problematic and comparator prescribers
2014
2014
Chronic pain, addiction, and Zohydro.
Twenty-nine state attorneys general have asked the FDA to reconsider its approval of the opioid Zohydro, which lacks abuse… 
2013
2013
FDA denies request to block generic versions of Opana ER
FDA has denied Endo Health Solutions' petition to block generic forms of its opioid agonist Opana ER, which contains oxymorphone… 
2009
2009
Concentration of oxymorphone in postmortem fluids and tissue.
Oxymorphone, a semi-synthetic opioid analgesic, has been available as Numorphan since the 1950s in the form of injectable… 
2009
2009
The Pain Quality Response Profile of Oxymorphone Extended Release in the Treatment of Low Back Pain
ObjectiveIn controlled trials of analgesics, the primary outcome variable is most often a measure of global pain intensity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)